Cross talk with hematopoietic cells regulates the endothelial progenitor cell differentiation of CD34 positive cells

PLoS One. 2014 Aug 28;9(8):e106310. doi: 10.1371/journal.pone.0106310. eCollection 2014.

Abstract

Introduction: Despite the crucial role of endothelial progenitor cells (EPCs) in vascular regeneration, the specific interactions between EPCs and hematopoietic cells remain unclear.

Methods: In EPC colony forming assays, we first demonstrated that the formation of EPC colonies was drastically increased in the coculture of CD34+ and CD34- cells, and determined the optimal concentrations of CD34+ cells and CD34- cells for spindle-shaped EPC differentiation.

Results: Functionally, the coculture of CD34+ and CD34- cells resulted in a significant enhancement of adhesion, tube formation, and migration capacity compared with culture of CD34+ cells alone. Furthermore, blood flow recovery and capillary formation were remarkably increased by the coculture of CD34+ and CD34- cells in a murine hind-limb ischemia model. To elucidate further the role of hematopoietic cells in EPC differentiation, we isolated different populations of hematopoietic cells. T lymphocytes (CD3+) markedly accelerated the early EPC status of CD34+ cells, while macrophages (CD11b+) or megakaryocytes (CD41+) specifically promoted large EPC colonies.

Conclusion: Our results suggest that specific populations of hematopoietic cells play a role in the EPC differentiation of CD34+ cells, a finding that may aid in the development of a novel cell therapy strategy to overcome the quantitative and qualitative limitations of EPC therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, CD34 / metabolism*
  • Cell Differentiation
  • Cells, Cultured
  • Coculture Techniques
  • Cord Blood Stem Cell Transplantation
  • Disease Models, Animal
  • Endothelial Progenitor Cells / cytology
  • Endothelial Progenitor Cells / physiology*
  • Fetal Blood / cytology*
  • Fetal Blood / metabolism
  • Hindlimb / blood supply*
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Ischemia / therapy*
  • Male
  • Mice
  • Mice, Inbred BALB C

Substances

  • Antigens, CD34

Grants and funding

This study was supported by grants from the National Research Foundation funded by the Korean government (MEST) (2010-0020260, 2012R1A2A01045085, 2012M3A0C6049720) and a grant from the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A120247). The authors have read and understood the regulations and have nothing to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.